DGAT-1 inhibitors (Viking therapeutics)

N/A

Report date: 2025/03/18 18:19:58
NME

Base Information

Drug NameDGAT-1 inhibitors (Viking therapeutics)
Drug Alias NameDGAT-1 inhibitors (Ligand Pharmaceuticals)diacylglycerol O-acyltransferase 1 inhibitors (Ligand Pharmaceuticals)DGAT-1 inhibitors (Metabasis)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDiacylglycerol O-acyltransferase 1 inhibitors
TargetsDiacylglycerol O-acyltransferase 1
Therapy Area/IndicationsObesityLipid Metabolism Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMetabasis Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesViking Therapeutics Inc
Inactive CompaniesMetabasis Therapeutics IncLigand Pharmaceuticals Inc
Active IndicationsObesityLipid Metabolism Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A